Fate Therapeutics (FATE) Insider Trading & Ownership $0.88 +0.03 (+3.22%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$0.87 -0.01 (-0.86%) As of 03/27/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Fate Therapeutics (NASDAQ:FATE) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$668,579.52Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$25,352.29 Get FATE Insider Trade Alerts Want to know when executives and insiders are buying or selling Fate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FATE Insider Buying and Selling by Quarter Remove Ads Fate Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/10/2025Bahram ValamehrCEOSell8,705$1.54$13,405.70 1/10/2025Jerome Charles BressiInsiderSell5,980$1.55$9,269.00 12/20/2024Redmile Group, LlcDirectorBuy397,964$1.68$668,579.52 8/6/2024Yuan XuDirectorSell633$4.23$2,677.59 (Data available from 1/1/2013 forward) FATE Insider Trading Activity - Frequently Asked Questions Who is on Fate Therapeutics's Insider Roster? The list of insiders at Fate Therapeutics includes Bahram Valamehr, Brian T Powl, Cindy Tahl, Edward J Dulac III, J Scott Wolchko, Jerome Charles Bressi, John Mendlein, Mark Plavsic, Redmile Group, Llc, Shefali Agarwal, Yuan Xu, and Yu-Waye Chu. Learn more on insiders at FATE. What percentage of Fate Therapeutics stock is owned by insiders? 5.00% of Fate Therapeutics stock is owned by insiders. Learn more on FATE's insider holdings. Which Fate Therapeutics insiders have been buying company stock? The following insider purchased FATE shares in the last 24 months: Redmile Group, Llc ($1,108,603.12). How much insider buying is happening at Fate Therapeutics? Insiders have purchased a total of 488,294 FATE shares in the last 24 months for a total of $1,108,603.12 bought. Which Fate Therapeutics insiders have been selling company stock? The following insiders have sold FATE shares in the last 24 months: Bahram Valamehr ($62,772.68), Brian T Powl ($18,768.98), Cindy Tahl ($47,519.38), Edward J Dulac III ($78,196.82), J Scott Wolchko ($62,888.67), Jerome Charles Bressi ($9,269.00), Yuan Xu ($24,329.11), and Yu-Waye Chu ($16,635.24). How much insider selling is happening at Fate Therapeutics? Insiders have sold a total of 81,109 Fate Therapeutics shares in the last 24 months for a total of $320,379.88 sold. Fate Therapeutics Key ExecutivesMr. J. Scott Wolchko (Age 54)Founder, CEO, President & Director Compensation: $920.4kMr. Edward J. Dulac III (Age 48)Chief Financial Officer Compensation: $612.5kMs. Cindy R. Tahl J.D. (Age 51)General Counsel, Corporate Secretary & Compliance Officer Compensation: $612.5kDr. Bahram Valamehr Ph.D. (Age 47)Chief Research & Development Officer Compensation: $644.5kMr. Jim Beitel M.B.A.Senior Vice President of Corporate DevelopmentDr. Jerome Bressi Ph.D.Senior Vice President of Regulatory & QualityDr. Barbara HickingbottomSenior VP of Clinical Development More Insider Trading Tools from MarketBeat Related Companies Erasca Insider Selling Humacyte Insider Selling Upstream Bio Insider Selling Cartesian Therapeutics Insider Selling Entrada Therapeutics Insider Selling Eton Pharmaceuticals Insider Selling Mereo BioPharma Group Insider Selling Revance Therapeutics Insider Selling Rapport Therapeutics Insider Selling Solid Biosciences Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:FATE) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FATE Stock Free FATE Stock Alerts